STOCK TITAN

[SCHEDULE 13G/A] Integra LifeSciences Holdings SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: As of the date hereof, Morgan Stanley has ceased to be the beneficial owner of more than five percent of the class of securities.


SCHEDULE 13G



Morgan Stanley
Signature:Christopher O'Hara
Name/Title:Authorized Signatory, Morgan Stanley
Date:08/05/2025
Integra Lifesciences Hldgs Cp

NASDAQ:IART

IART Rankings

IART Latest News

IART Latest SEC Filings

IART Stock Data

1.10B
66.92M
13.97%
95.31%
9.23%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
PRINCETON